title: Posttransplant hypertension in blacks versus nonblacks.
authors.affiliation: Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, Pennsylvania.
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: H
authors.initials: H
authors.lastname: Woods
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: W
authors.initials: W
authors.lastname: Irish
authors.forename: J
authors.initials: J
authors.lastname: McMichael
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000293:Adolescent; D000328:Adult; D001741:Black or African American; D000959:Antihypertensive Agents / Q000627:therapeutic use; D044383:Black People; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000601:surgery*; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D044469:Racial Groups; D012189:Retrospective Studies; D012737:Sex Factors; D013997:Time Factors; D044465:White People
chemical_list: D000959:Antihypertensive Agents